Industry News

Healthcare giant set to transfer up to 140 jobs to plant in China ; HULL: One of city's biggest employers to relocate roles by July 2016
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion in the new facility
Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion� in the new facility.
BRIEF: Amgen will shut Seattle, Bothell operations
FDA Accepts for Review Adamis' New Drug Application for Its Epinephrine Pre-Filled Syringe
FDA Accepts for Review Adamis' New Drug Application for Its Epinephrine Pre-Filled Syringe
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
N.J. pharma: New faces, small spaces
"Graying" Population of Infertility Patients Brings New Challenges to Medical Practice and Society, Study at Center for Human Reproduction Finds
Ortho-Clinical Diagnostics, Inc. Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE� (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Safety problems at US germ labs acknowledged
"Graying" Population of Infertility Patients Brings New Challenges to Medical Practice and Society, Study at Center for Human Reproduction Finds
BioAlliance Pharma and Topotarget Confirm Cross-border Merger
FDA Accepts for Review Adamis' New Drug Application for Its Epinephrine Pre-Filled Syringe
Safety problems at US germ labs acknowledged
Decision Resources Group Releases 'ePharma Physician 2014' Study
Concert Pharmaceuticals Cites Lifting of FDA Partial Clinical Hold for CTP-354
Medivir's sNDA Secures U.S. FDA Priority Review
InterMune Updates on FDA Breakthough Therapy Designation for Pirfenidone
AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso�
FDA Approves New Extended-release Oxycodone with Abuse-Deterrent Properties
N.J. pharma: New faces, small spaces